Your Fertility Struggles May Have a Genetic Explanation.

MTHFR controls methylation, one of the most fundamental processes in every human cell. Methylation is how your cells turn genes on and off, how they repair DNA, and how they stabilize chromosomes. It’s especially critical during pregnancy because your embryo is developing new cells by the billions every single day, and every one of those cells requires proper methylation patterns.

The MTHFR C677T variant, carried by roughly 40% of people with European ancestry, reduces this enzyme’s efficiency by 40 to 70%. That means if you carry this variant, your cells are methylating DNA at a fraction of the normal rate. During the sensitive window when your embryo is developing, this slowdown can interfere with neural tube closure, chromosome stability, and the epigenetic patterns that tell embryonic cells what to become. You can have perfect hormone levels and a structurally normal embryo and still have it fail because the methylation machinery is running too slowly.

For women with MTHFR variants, pregnancy loss in the first trimester is more common, even after successful implantation. Sperm DNA methylation is also affected if your partner carries the variant. Homocysteine levels are often elevated, which can damage the uterine blood vessels that nourish a growing pregnancy. Many women don’t realize until they’ve had multiple miscarriages that the problem was never random bad luck. It was a slow methylation engine that couldn’t keep up with the demands of early pregnancy.

FSHR is your ovary’s receptor for FSH (follicle-stimulating hormone). FSH is the signal that tells your ovaries to grow eggs. The signal only works if your ovaries have functioning FSHR receptors. Without them, FSH is like shouting into a room where nobody can hear you. The eggs won’t grow no matter how much hormone you inject.

The N680S variant comes in different forms. Women who have the S/S genotype (roughly 10 to 15% of the population) have FSHR receptors that are less sensitive to FSH. This means your ovaries simply don’t respond normally to standard fertility drug doses. What looks like ‘poor ovarian response’ on your ultrasound during an IVF cycle is actually a genetic difference in receptor sensitivity, not an age or reserve problem. Standard stimulation protocols won’t work for you because your ovaries are receiving the signal but can’t hear it as clearly as other women’s do.

For women with the S/S variant, the first IVF cycle is often disappointing. You get fewer eggs than expected, lower fertilization rates, and fewer embryos. Your doctor may increase the dose next cycle, but if the problem is genetic receptor sensitivity, more of the same hormone won’t fix it. You need a different protocol altogether, higher total doses, longer stimulation windows, or different drug combinations that bypass the insensitive receptor.

ESR1 is your estrogen receptor, the lock that estrogen fits into like a key. Your uterus is lined with estrogen receptors, and during the second half of your cycle, estrogen is supposed to prime the endometrium to accept an implanting embryo. If your estrogen receptors aren’t working optimally, your endometrium never becomes fully receptive, even if your estrogen levels are perfect.

The PvuII and XbaI variants affect how sensitive your endometrial cells are to estrogen signaling. About 40% of women carry variants that reduce ESR1 sensitivity. This means your endometrium may look structurally normal on ultrasound but remain functionally unreceptive to implantation. The embryo arrives at the window of implantation, but the uterus doesn’t recognize it or isn’t prepared to accept it. Implantation fails even though nothing obvious is wrong.

For women with ESR1 variants, the frustration is acute: you achieve fertilization, you get a beautiful embryo, the timing seems perfect, and yet implantation doesn’t happen or a chemical pregnancy results. Some women go through multiple IVF cycles before realizing the problem is uterine receptivity, not egg or embryo quality. Estrogen-based protocols may not be as effective for you as they are for other women, even at higher doses.

COMT is the enzyme responsible for clearing estrogen from your body. When estrogen is metabolized normally, it’s broken down and excreted. When COMT is slow, estrogen accumulates. Elevated estrogen is linked to two of the most common fertility killers: endometriosis and PCOS. Both dramatically impair fertility in different ways.

The Val158Met variant comes in three versions. People who are homozygous slow (Met/Met), roughly 25% of those with European ancestry, metabolize estrogen very slowly. This leads to chronically elevated estrogen, which drives inflammation, abnormal uterine tissue growth, and hormonal imbalance. Elevated estrogen is the soil in which endometriosis grows. It also worsens PCOS symptoms and makes the hormonal environment hostile to conception.

If you have slow COMT and endometriosis, your fertility is fighting an uphill battle. Inflammation in your pelvis damages your fallopian tubes and makes implantation less likely. If you have slow COMT and PCOS, you’re battling insulin resistance and androgen excess on top of elevated estrogen. Your cycles may be irregular, your ovulation uncertain, and your body may struggle to support a pregnancy even if conception occurs.

VDR is your vitamin D receptor, the protein that allows your cells to use vitamin D. Vitamin D is not just a bone nutrient. It’s an immune regulator. During pregnancy, your immune system has to do something remarkable: it has to tolerate the embryo and placenta, which are genetically foreign. If your immune system doesn’t tolerate them, you get miscarriage. Vitamin D signaling is one of the central mechanisms that keeps your immune system from attacking your own pregnancy.

VDR variants (FokI, BsmI, ApaI, TaqI) determine how efficiently your cells respond to vitamin D. Some variants make your VDR more or less active. If you carry variants that reduce VDR activity, you may be vitamin D deficient at the cellular level even if your blood levels are adequate. This impairs immune tolerance and increases miscarriage risk, especially in early pregnancy. Your body may be treating your developing embryo as a threat rather than a welcome guest.

Women with VDR variants and low vitamin D status have significantly higher rates of first-trimester loss. If you’ve had multiple miscarriages and your bloodwork shows low-normal vitamin D, your VDR genetics may be the missing link. Your body may need much higher vitamin D levels than standard recommendations suggest in order to achieve immune tolerance and carry a pregnancy to term.

FMR1 is a gene on the X chromosome that protects ovarian cells. Women who carry a premutation in FMR1 (55 to 200 CGG repeats) have a condition called Fragile X-associated premature ovarian insufficiency (FXPOI). The premutation doesn’t cause Fragile X syndrome (that requires the full mutation), but it does affect egg health and ovarian lifespan.

Roughly 1 in 250 women carry an FMR1 premutation. Women with the premutation experience accelerated ovarian aging, elevated FSH levels, and a shorter reproductive window than women without it. Your ovaries are running through eggs faster than they should be. You may have a normal antral follicle count and normal FSH at age 30, but by 35 your reserve has dropped dramatically. Fertility declines faster. Miscarriage risk climbs higher because the remaining eggs are older and more chromosomally abnormal.

For women with FMR1 premutations, the time pressure in fertility is real and significant. Waiting another year or two hoping that conception will happen spontaneously is actually dangerous. Your ovarian reserve may decline 30 to 50% in a year or two. Your reproductive window is narrower than it should be, which changes the entire calculus around when to pursue fertility treatment.